ArticleBMC gastroenterology2024

Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/CD166 + by inhibiting programmed death-ligand 1.

Yulong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.